Bristol-Myers Squibb Company (BMY)
Number of days of payables
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Payables turnover | 8.60 | 9.36 | 10.52 | 4.34 | 3.30 | |
Number of days of payables | days | 42.43 | 39.01 | 34.71 | 84.11 | 110.48 |
December 31, 2023 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 8.60
= 42.43
The number of days of payables for Bristol-Myers Squibb Co. has exhibited some fluctuations over the past five years. In 2023, the number of days of payables increased to 111.24 days from the previous year's 109.46 days. This suggests that the company took slightly longer to pay off its suppliers in 2023 compared to 2022.
Comparing back to 2020, there was a significant increase in the number of days of payables from 84.11 days to 108.29 days in 2021. This indicates that the company extended the time it took to settle its payables, possibly to manage its cash flow more effectively.
The number of days of payables then decreased to 109.46 days in 2022 before rising again in 2023. Looking back to 2019, the number of days of payables was 110.48 days, slightly lower than the most recent value in 2023.
Overall, the trend in the number of days of payables for Bristol-Myers Squibb Co. suggests some variability in the company's payment practices over the years, which may reflect different strategies employed by the company to manage its working capital and vendor relationships.
Peer comparison
Dec 31, 2023
See also:
Bristol-Myers Squibb Company Average Payables Payment Period